Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease

Authors: Sabrina H Rossi, Emily P McQuarrie, William H Miller, Ruth M Mackenzie, Jane A Dymott, María U Moreno, Chiara Taurino, Ashley M Miller, Ulf Neisius, Geoffrey A Berg, Zivile Valuckiene, Jonathan A Hannay, Anna F Dominiczak, Christian Delles

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Chronic kidney disease (CKD) and coronary artery disease (CAD) are independently associated with increased vascular stiffness. We examined whether renal function contributes to vascular stiffness independently of CAD status.

Methods

We studied 160 patients with CAD and 169 subjects without CAD. The 4-variable MDRD formula was used to estimate glomerular filtration rate (eGFR); impaired renal function was defined as eGFR <60 mL/min. Carotid-femoral pulse wave velocity (PWV) was measured with the SphygmoCor® device. Circulating biomarkers were assessed in plasma using xMAP® multiplexing technology.

Results

Patients with CAD and impaired renal function had greater PWV compared to those with CAD and normal renal function (10.2 [9.1;11.2] vs 7.3 [6.9;7.7] m/s; P < 0.001). In all patients, PWV was a function of eGFR (β = −0.293; P < 0.001) even after adjustment for age, sex, systolic blood pressure, body mass index and presence or absence of CAD. Patients with CAD and impaired renal function had higher levels of adhesion and inflammatory molecules including E-selectin and osteopontin (all P < 0.05) compared to those with CAD alone, but had similar levels of markers of oxidative stress.

Conclusions

Renal function is a determinant of vascular stiffness even in patients with severe atherosclerotic disease. This was paralleled by differences in markers of cell adhesion and inflammation. Increased vascular stiffness may therefore be linked to inflammatory remodeling of the vasculature in people with impaired renal function, irrespective of concomitant atherosclerotic disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wang MC, Tsai WC, Chen JY, Huang JJ: Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis. 2005, 45: 494-501. 10.1053/j.ajkd.2004.11.011.CrossRefPubMed Wang MC, Tsai WC, Chen JY, Huang JJ: Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis. 2005, 45: 494-501. 10.1053/j.ajkd.2004.11.011.CrossRefPubMed
2.
go back to reference Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999, 99: 2434-2439. 10.1161/01.CIR.99.18.2434.CrossRefPubMed Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999, 99: 2434-2439. 10.1161/01.CIR.99.18.2434.CrossRefPubMed
3.
go back to reference Karras A, Haymann JP, Bozec E, Metzger M, Jacquot C, Maruani G, Houillier P, Froissart M, Stengel B, Guardiola P, et al: Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension. 2012, 60: 1451-1457. 10.1161/HYPERTENSIONAHA.112.197210.CrossRefPubMed Karras A, Haymann JP, Bozec E, Metzger M, Jacquot C, Maruani G, Houillier P, Froissart M, Stengel B, Guardiola P, et al: Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension. 2012, 60: 1451-1457. 10.1161/HYPERTENSIONAHA.112.197210.CrossRefPubMed
4.
go back to reference Chen SC, Chang JM, Liu WC, Tsai YC, Tsai JC, Hsu PC, Lin TH, Lin MY, Su HM, Hwang SJ, et al: Brachial-ankle pulse wave velocity and rate of renal function decline and mortality in chronic kidney disease. Clin J Am Soc Nephrol. 2011, 6: 724-732. 10.2215/CJN.07700910.CrossRefPubMedPubMedCentral Chen SC, Chang JM, Liu WC, Tsai YC, Tsai JC, Hsu PC, Lin TH, Lin MY, Su HM, Hwang SJ, et al: Brachial-ankle pulse wave velocity and rate of renal function decline and mortality in chronic kidney disease. Clin J Am Soc Nephrol. 2011, 6: 724-732. 10.2215/CJN.07700910.CrossRefPubMedPubMedCentral
5.
go back to reference Tomiyama H, Koji Y, Yambe M, Shiina K, Motobe K, Yamada J, Shido N, Tanaka N, Chikamori T, Yamashina A: Brachial-ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. Circ J. 2005, 69: 815-822. 10.1253/circj.69.815.CrossRefPubMed Tomiyama H, Koji Y, Yambe M, Shiina K, Motobe K, Yamada J, Shido N, Tanaka N, Chikamori T, Yamashina A: Brachial-ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. Circ J. 2005, 69: 815-822. 10.1253/circj.69.815.CrossRefPubMed
6.
go back to reference Covic A, Haydar AA, Bhamra-Ariza P, Gusbeth-Tatomir P, Goldsmith DJ: Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J Nephrol. 2005, 18: 388-396.PubMed Covic A, Haydar AA, Bhamra-Ariza P, Gusbeth-Tatomir P, Goldsmith DJ: Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J Nephrol. 2005, 18: 388-396.PubMed
7.
go back to reference Zimmerli LU, Mark PB, Steedman T, Foster JE, Berg GA, Dargie HJ, Jardine AG, Delles C, Dominiczak AF: Vascular function in patients with end-stage renal disease and/or coronary artery disease: a cardiac magnetic resonance imaging study. Kidney Int. 2007, 71: 68-73. 10.1038/sj.ki.5002024.CrossRefPubMed Zimmerli LU, Mark PB, Steedman T, Foster JE, Berg GA, Dargie HJ, Jardine AG, Delles C, Dominiczak AF: Vascular function in patients with end-stage renal disease and/or coronary artery disease: a cardiac magnetic resonance imaging study. Kidney Int. 2007, 71: 68-73. 10.1038/sj.ki.5002024.CrossRefPubMed
8.
go back to reference Ilyas B, Dhaun N, Markie D, Stansell P, Goddard J, Newby DE, Webb DJ: Renal function is associated with arterial stiffness and predicts outcome in patients with coronary artery disease. QJM. 2009, 102: 183-191.CrossRefPubMed Ilyas B, Dhaun N, Markie D, Stansell P, Goddard J, Newby DE, Webb DJ: Renal function is associated with arterial stiffness and predicts outcome in patients with coronary artery disease. QJM. 2009, 102: 183-191.CrossRefPubMed
9.
go back to reference Packard RR, Libby P: Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008, 54: 24-38.CrossRefPubMed Packard RR, Libby P: Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008, 54: 24-38.CrossRefPubMed
10.
go back to reference Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG: Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant. 2008, 23: 586-593.CrossRefPubMed Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG: Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant. 2008, 23: 586-593.CrossRefPubMed
11.
go back to reference Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002, 62: 1524-1538. 10.1046/j.1523-1755.2002.00600.x.CrossRefPubMed Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002, 62: 1524-1538. 10.1046/j.1523-1755.2002.00600.x.CrossRefPubMed
12.
go back to reference Delles C, Dymott JA, Neisius U, Rocchiccioli JP, Bryce GJ, Moreno MU, Carty DM, Berg GA, Hamilton CA, Dominiczak AF: Reduced LDL-cholesterol levels in patients with coronary artery disease are paralleled by improved endothelial function: an observational study in patients from 2003 and 2007. Atherosclerosis. 2010, 211: 271-277. 10.1016/j.atherosclerosis.2010.01.014.CrossRefPubMedPubMedCentral Delles C, Dymott JA, Neisius U, Rocchiccioli JP, Bryce GJ, Moreno MU, Carty DM, Berg GA, Hamilton CA, Dominiczak AF: Reduced LDL-cholesterol levels in patients with coronary artery disease are paralleled by improved endothelial function: an observational study in patients from 2003 and 2007. Atherosclerosis. 2010, 211: 271-277. 10.1016/j.atherosclerosis.2010.01.014.CrossRefPubMedPubMedCentral
13.
go back to reference Berry C, Zimmerli LU, Steedman T, Foster JE, Dargie HJ, Berg GA, Dominiczak AF, Delles C: Cardiac magnetic resonance findings predict increased resource utilization in elective coronary artery bypass grafting. Clin Sci (Lond). 2008, 114: 423-430. 10.1042/CS20070337.CrossRef Berry C, Zimmerli LU, Steedman T, Foster JE, Dargie HJ, Berg GA, Dominiczak AF, Delles C: Cardiac magnetic resonance findings predict increased resource utilization in elective coronary artery bypass grafting. Clin Sci (Lond). 2008, 114: 423-430. 10.1042/CS20070337.CrossRef
14.
go back to reference Taurino C, Miller WH, McBride MW, McClure JD, Khanin R, Moreno MU, Dymott JA, Delles C, Dominiczak AF: Gene expression profiling in whole blood of patients with coronary artery disease. Clin Sci (Lond). 2010, 119: 335-343. 10.1042/CS20100043.CrossRef Taurino C, Miller WH, McBride MW, McClure JD, Khanin R, Moreno MU, Dymott JA, Delles C, Dominiczak AF: Gene expression profiling in whole blood of patients with coronary artery disease. Clin Sci (Lond). 2010, 119: 335-343. 10.1042/CS20100043.CrossRef
15.
go back to reference McQuarrie EP, Patel RK, Mark PB, Delles C, Connell J, Dargie HJ, Steedman T, Jardine AG: Association between proteinuria and left ventricular mass index: a cardiac MRI study in patients with chronic kidney disease. Nephrol Dial Transplant. 2010, 26: 933-938.CrossRefPubMed McQuarrie EP, Patel RK, Mark PB, Delles C, Connell J, Dargie HJ, Steedman T, Jardine AG: Association between proteinuria and left ventricular mass index: a cardiac MRI study in patients with chronic kidney disease. Nephrol Dial Transplant. 2010, 26: 933-938.CrossRefPubMed
16.
go back to reference Delles C, Zimmerli LU, McGrane DJ, Koh-Tan CH, Pathi VL, McKay AJ, Steedman T, Dargie HJ, Hamilton CA, Dominiczak AF: Vascular stiffness is related to superoxide generation in the vessel wall. J Hypertens. 2008, 26: 946-955. 10.1097/HJH.0b013e3282f7677c.CrossRefPubMed Delles C, Zimmerli LU, McGrane DJ, Koh-Tan CH, Pathi VL, McKay AJ, Steedman T, Dargie HJ, Hamilton CA, Dominiczak AF: Vascular stiffness is related to superoxide generation in the vessel wall. J Hypertens. 2008, 26: 946-955. 10.1097/HJH.0b013e3282f7677c.CrossRefPubMed
17.
go back to reference Al Benna S, Hamilton CA, McClure JD, Rogers PN, Berg GA, Ford I, Delles C, Dominiczak AF: Low-density lipoprotein cholesterol determines oxidative stress and endothelial dysfunction in saphenous veins from patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2006, 26: 218-223. 10.1161/01.ATV.0000193626.22269.45.CrossRefPubMed Al Benna S, Hamilton CA, McClure JD, Rogers PN, Berg GA, Ford I, Delles C, Dominiczak AF: Low-density lipoprotein cholesterol determines oxidative stress and endothelial dysfunction in saphenous veins from patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2006, 26: 218-223. 10.1161/01.ATV.0000193626.22269.45.CrossRefPubMed
18.
go back to reference Fortuno A, Olivan S, Beloqui O, San Jose G, Moreno MU, Diez J, Zalba G: Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension. J Hypertens. 2004, 22: 2169-2175. 10.1097/00004872-200411000-00020.CrossRefPubMed Fortuno A, Olivan S, Beloqui O, San Jose G, Moreno MU, Diez J, Zalba G: Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension. J Hypertens. 2004, 22: 2169-2175. 10.1097/00004872-200411000-00020.CrossRefPubMed
19.
go back to reference Fink B, Dikalov S, Bassenge E: A new approach for extracellular spin trapping of nitroglycerin-induced superoxide radicals both in vitro and in vivo. Free Radic Biol Med. 2000, 28: 121-128. 10.1016/S0891-5849(99)00228-2.CrossRefPubMed Fink B, Dikalov S, Bassenge E: A new approach for extracellular spin trapping of nitroglycerin-induced superoxide radicals both in vitro and in vivo. Free Radic Biol Med. 2000, 28: 121-128. 10.1016/S0891-5849(99)00228-2.CrossRefPubMed
20.
go back to reference Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S: Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002, 39: 10-15. 10.1161/hy0102.099031.CrossRefPubMed Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S: Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002, 39: 10-15. 10.1161/hy0102.099031.CrossRefPubMed
21.
go back to reference Chirinos JA, Zambrano JP, Chakko S, Veerani A, Schob A, Willens HJ, Perez G, Mendez AJ: Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension. 2005, 45: 980-985. 10.1161/01.HYP.0000165025.16381.44.CrossRefPubMed Chirinos JA, Zambrano JP, Chakko S, Veerani A, Schob A, Willens HJ, Perez G, Mendez AJ: Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension. 2005, 45: 980-985. 10.1161/01.HYP.0000165025.16381.44.CrossRefPubMed
22.
go back to reference Kawamoto R, Kohara K, Tabara Y, Miki T, Ohtsuka N, Kusunoki T, Yorimitsu N: An association between decreased estimated glomerular filtration rate and arterial stiffness. Intern Med. 2008, 47: 593-598. 10.2169/internalmedicine.47.0825.CrossRefPubMed Kawamoto R, Kohara K, Tabara Y, Miki T, Ohtsuka N, Kusunoki T, Yorimitsu N: An association between decreased estimated glomerular filtration rate and arterial stiffness. Intern Med. 2008, 47: 593-598. 10.2169/internalmedicine.47.0825.CrossRefPubMed
23.
go back to reference Schillaci G, Pirro M, Mannarino MR, Pucci G, Savarese G, Franklin SS, Mannarino E: Relation between renal function within the normal range and central and peripheral arterial stiffness in hypertension. Hypertension. 2006, 48: 616-621. 10.1161/01.HYP.0000240346.42873.f6.CrossRefPubMed Schillaci G, Pirro M, Mannarino MR, Pucci G, Savarese G, Franklin SS, Mannarino E: Relation between renal function within the normal range and central and peripheral arterial stiffness in hypertension. Hypertension. 2006, 48: 616-621. 10.1161/01.HYP.0000240346.42873.f6.CrossRefPubMed
24.
go back to reference Carty DM, Anderson LA, Freeman DJ, Welsh PI, Brennand JE, Dominiczak AF, Delles C: Early pregnancy soluble E-selectin concentrations and risk of preeclampsia. J Hypertens. 2012, 30: 954-959. 10.1097/HJH.0b013e328352573b.CrossRefPubMed Carty DM, Anderson LA, Freeman DJ, Welsh PI, Brennand JE, Dominiczak AF, Delles C: Early pregnancy soluble E-selectin concentrations and risk of preeclampsia. J Hypertens. 2012, 30: 954-959. 10.1097/HJH.0b013e328352573b.CrossRefPubMed
25.
go back to reference Suliman ME, Qureshi AR, Heimburger O, Lindholm B, Stenvinkel P: Soluble adhesion molecules in end-stage renal disease: a predictor of outcome. Nephrol Dial Transplant. 2006, 21: 1603-1610. 10.1093/ndt/gfl005.CrossRefPubMed Suliman ME, Qureshi AR, Heimburger O, Lindholm B, Stenvinkel P: Soluble adhesion molecules in end-stage renal disease: a predictor of outcome. Nephrol Dial Transplant. 2006, 21: 1603-1610. 10.1093/ndt/gfl005.CrossRefPubMed
26.
go back to reference Tripepi G, Mallamaci F, Zoccali C: Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol. 2005, 16 Suppl 1:S83-8: S83-S88.CrossRef Tripepi G, Mallamaci F, Zoccali C: Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol. 2005, 16 Suppl 1:S83-8: S83-S88.CrossRef
27.
go back to reference Malatino LS, Stancanelli B, Cataliotti A, Bellanuova I, Fatuzzo P, Rapisarda F, Leonardis D, Tripepi G, Mallamaci F, Zoccali C: Circulating E-selectin as a risk marker in patients with end-stage renal disease. J Intern Med. 2007, 262: 479-487. 10.1111/j.1365-2796.2007.01841.x.CrossRefPubMed Malatino LS, Stancanelli B, Cataliotti A, Bellanuova I, Fatuzzo P, Rapisarda F, Leonardis D, Tripepi G, Mallamaci F, Zoccali C: Circulating E-selectin as a risk marker in patients with end-stage renal disease. J Intern Med. 2007, 262: 479-487. 10.1111/j.1365-2796.2007.01841.x.CrossRefPubMed
28.
go back to reference Ross R: Atherosclerosis–an inflammatory disease. N Engl J Med. 1999, 340: 115-126. 10.1056/NEJM199901143400207.CrossRefPubMed Ross R: Atherosclerosis–an inflammatory disease. N Engl J Med. 1999, 340: 115-126. 10.1056/NEJM199901143400207.CrossRefPubMed
29.
go back to reference Lorenzen J, Kramer R, Kliem V, Bode-Boeger SM, Veldink H, Haller H, Fliser D, Kielstein JT: Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease. Eur J Clin Invest. 2010, 40: 294-300. 10.1111/j.1365-2362.2010.02271.x.CrossRefPubMed Lorenzen J, Kramer R, Kliem V, Bode-Boeger SM, Veldink H, Haller H, Fliser D, Kielstein JT: Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease. Eur J Clin Invest. 2010, 40: 294-300. 10.1111/j.1365-2362.2010.02271.x.CrossRefPubMed
30.
go back to reference Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K: Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest. 1993, 92: 2814-2820. 10.1172/JCI116901.CrossRefPubMedPubMedCentral Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K: Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest. 1993, 92: 2814-2820. 10.1172/JCI116901.CrossRefPubMedPubMedCentral
31.
go back to reference Minoretti P, Falcone C, Calcagnino M, Emanuele E, Buzzi MP, Coen E, Geroldi D: Prognostic significance of plasma osteopontin levels in patients with chronic stable angina. Eur Heart J. 2006, 27: 802-807. 10.1093/eurheartj/ehi730.CrossRefPubMed Minoretti P, Falcone C, Calcagnino M, Emanuele E, Buzzi MP, Coen E, Geroldi D: Prognostic significance of plasma osteopontin levels in patients with chronic stable angina. Eur Heart J. 2006, 27: 802-807. 10.1093/eurheartj/ehi730.CrossRefPubMed
32.
go back to reference Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000, 20: 1595-1599. 10.1161/01.ATV.20.6.1595.CrossRefPubMed Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000, 20: 1595-1599. 10.1161/01.ATV.20.6.1595.CrossRefPubMed
33.
go back to reference Delles C, Raff U, Mimran A, Fauvel JP, Ruilope LM, Schmieder RE: Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes. Am J Hypertens. 2008, 21: 1330-1336. 10.1038/ajh.2008.297.CrossRefPubMed Delles C, Raff U, Mimran A, Fauvel JP, Ruilope LM, Schmieder RE: Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes. Am J Hypertens. 2008, 21: 1330-1336. 10.1038/ajh.2008.297.CrossRefPubMed
34.
go back to reference Komura N, Kihara S, Sonoda M, Maeda N, Tochino Y, Funahashi T, Shimomura I: Increment and impairment of adiponectin in renal failure. Cardiovasc Res. 2010, 86: 471-477. 10.1093/cvr/cvp415.CrossRefPubMed Komura N, Kihara S, Sonoda M, Maeda N, Tochino Y, Funahashi T, Shimomura I: Increment and impairment of adiponectin in renal failure. Cardiovasc Res. 2010, 86: 471-477. 10.1093/cvr/cvp415.CrossRefPubMed
35.
go back to reference Drury PL, Ting R, Zannino D, Ehnholm C, Flack J, Whiting M, Fassett R, Ansquer JC, Dixon P, Davis TM, et al: Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia. 2011, 54: 32-43. 10.1007/s00125-010-1854-1.CrossRefPubMed Drury PL, Ting R, Zannino D, Ehnholm C, Flack J, Whiting M, Fassett R, Ansquer JC, Dixon P, Davis TM, et al: Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia. 2011, 54: 32-43. 10.1007/s00125-010-1854-1.CrossRefPubMed
36.
go back to reference Delles C, Jardine AG: Renal function and cardiovascular events: relevance of eGFR and albuminuria in patients with diabetes. Diabetologia. 2011, 54: 4-6. 10.1007/s00125-010-1942-2.CrossRefPubMed Delles C, Jardine AG: Renal function and cardiovascular events: relevance of eGFR and albuminuria in patients with diabetes. Diabetologia. 2011, 54: 4-6. 10.1007/s00125-010-1942-2.CrossRefPubMed
37.
go back to reference Orlova IA, Nuraliev EY, Yarovaya EB, Ageev FT: Prognostic value of changes in arterial stiffness in men with coronary artery disease. Vasc Health Risk Manag. 2010, 6: 1015-1021.CrossRefPubMedPubMedCentral Orlova IA, Nuraliev EY, Yarovaya EB, Ageev FT: Prognostic value of changes in arterial stiffness in men with coronary artery disease. Vasc Health Risk Manag. 2010, 6: 1015-1021.CrossRefPubMedPubMedCentral
38.
go back to reference Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ: Arterial stiffness and cardiovascular events: the Framingham heart study. Circulation. 2010, 121: 505-511. 10.1161/CIRCULATIONAHA.109.886655.CrossRefPubMedPubMedCentral Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ: Arterial stiffness and cardiovascular events: the Framingham heart study. Circulation. 2010, 121: 505-511. 10.1161/CIRCULATIONAHA.109.886655.CrossRefPubMedPubMedCentral
39.
go back to reference Mattace-Raso FU, van der Cammen TJ, Hofman A, Van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, et al: Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam study. Circulation. 2006, 113: 657-663. 10.1161/CIRCULATIONAHA.105.555235.CrossRefPubMed Mattace-Raso FU, van der Cammen TJ, Hofman A, Van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, et al: Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam study. Circulation. 2006, 113: 657-663. 10.1161/CIRCULATIONAHA.105.555235.CrossRefPubMed
40.
go back to reference Blacher J, Safar ME, Pannier B, Guerin AP, Marchais SJ, London GM: Prognostic significance of arterial stiffness measurements in end-stage renal disease patients. Curr Opin Nephrol Hypertens. 2002, 11: 629-634. 10.1097/00041552-200211000-00010.CrossRefPubMed Blacher J, Safar ME, Pannier B, Guerin AP, Marchais SJ, London GM: Prognostic significance of arterial stiffness measurements in end-stage renal disease patients. Curr Opin Nephrol Hypertens. 2002, 11: 629-634. 10.1097/00041552-200211000-00010.CrossRefPubMed
Metadata
Title
Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease
Authors
Sabrina H Rossi
Emily P McQuarrie
William H Miller
Ruth M Mackenzie
Jane A Dymott
María U Moreno
Chiara Taurino
Ashley M Miller
Ulf Neisius
Geoffrey A Berg
Zivile Valuckiene
Jonathan A Hannay
Anna F Dominiczak
Christian Delles
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-173

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine